What has remained far murkier is how the loss of ATM reshapes the activity of microRNAs, the tiny non-coding RNA molecules that fine-tune gene expression after transcription. MicroRNAs destabilize messenger RNAs or block their translation into proteins, and in the DNA damage response they modulate repair, checkpoint control, apoptosis, senescence and cell-cycle progression. The relationship between ATM and microRNAs runs in both directions. Damage-responsive microRNAs can be transcribed under the control of p53, which itself sits downstream of ATM. ATM can directly activate microRNAs and even promote global microRNA biogenesis: a landmark study showed that ATM phosphorylates the RNA-binding protein KSRP, physically linking ATM signaling to the microRNA processing machinery. Conversely, the microRNA miR-421 can suppress ATM expression by targeting the ATM 3-prime untranslated region, experimentally producing checkpoint defects and increased radiosensitivity. This bidirectional wiring means that a cell lacking functional ATM could suffer microRNA dysregulation through multiple, overlapping mechanisms.

A new study published in Molecular Biology Reports by Muhammad Junaid Iqbal, Michele Menotta and colleagues at the University of Urbino Carlo Bo, together with collaborators in China and Pakistan, set out to characterize this interface in a controlled experimental system. Rather than attempting an unbiased biomarker screen, the team designed a mechanistically motivated assay of four predefined candidate microRNAs chosen to represent complementary arms of the ATM-associated DNA damage response and checkpoint network. miR-34a-5p was selected as the canonical p53-responsive microRNA involved in apoptosis, cell-cycle arrest and senescence, whose mature activity can also be modulated through ATM-dependent 5-prime-end phosphorylation after DNA damage. miR-26a-5p was included for its reported links to genotoxic stress and checkpoint regulation, including regulation of the kinases WEE1 and CHK1 and PTEN-AKT-associated phenotypes. miR-106b-5p and miR-20a-5p were chosen to represent the G1/S and RB/E2F checkpoint-modulatory arm, since miR-106b family members regulate the p21 cell-cycle inhibitor and miR-20a participates in c-Myc/E2F1-associated G1 checkpoint control.

The experimental design was deliberately simple and tightly controlled. The researchers compared one ATM-proficient human fibroblast control line, AG09429, with three patient-derived A-T fibroblast lines, GM00648, GM05849 and GM09607, all obtained from the Coriell Institute for Medical Research. Two of the lines were immortalized in-house by hTERT transduction, while the other two were obtained as transformed lines. To inflict controlled genotoxic stress, the team used bleomycin, a radiomimetic glycopeptide antibiotic that generates oxidative DNA lesions and strand breaks through an iron- and oxygen-dependent mechanism. Because ATM is the central transducer of double-strand break signaling, bleomycin provided a clean way to compare basal and stress-responsive microRNA behavior. Cultures were treated with 8 micrograms per milliliter of bleomycin for three hours, then allowed to recover for 24 hours before RNA extraction. Mature microRNA abundance was quantified by TaqMan reverse transcription quantitative PCR, normalized to the endogenous control miR-16-5p and analyzed with the comparative Ct method across three independent biological replicates per condition.

The basal results were striking. Under untreated conditions, miR-34a-5p showed the most pronounced difference between the control and the A-T panel: all three A-T lines displayed a highly significant reduction in miR-34a-5p compared with the untreated control, each with a p-value below 0.001 after Dunnett’s multiple-comparison testing. miR-26a-5p followed the same pattern, with significantly lower expression in all three A-T lines. miR-106b-5p showed a weaker, line-dependent profile, significantly reduced in two of the three A-T lines but not the third, while miR-20a-5p showed no significant basal differences at all. In other words, the dominant basal phenotype was a reproducible depletion of exactly the two microRNAs most directly tied to p53 signaling and checkpoint regulation, a pattern biologically coherent with impaired ATM-p53 signaling in these cells.

After bleomycin exposure, the between-line differences persisted. miR-34a-5p and miR-26a-5p remained significantly lower in all three bleomycin-treated A-T lines relative to the single bleomycin-treated control, again with p-values below 0.001. Meanwhile, miR-106b-5p and miR-20a-5p behaved in a more condition-dependent manner, with the strongest divergence seen in the AT648 line, which showed significantly higher expression of both microRNAs than the treated control. Crucially, the researchers separated between-line differences from acute treatment responses by performing paired within-line analyses. In the control fibroblasts, bleomycin significantly induced miR-34a-5p and reduced miR-106b-5p, a selective stress response rather than broad induction of the whole panel. AT648 showed the most dramatic behavior: all four candidate microRNAs were significantly induced after treatment, yet the induced miR-34a-5p and miR-26a-5p still failed to reach control-like levels. AT5849 showed only a significant reduction of miR-106b-5p, and AT9607 showed significant induction of miR-34a-5p alone. The response, in short, was heterogeneous and cell-line specific rather than a uniform A-T signature.

To organize the biological context of the candidate panel, the team performed target-based enrichment analysis using DIANA-miRPath v4.0 with the experimentally validated miRTarBase 2022 interaction database, complemented by a sensitivity analysis with TarBase v8.0 and a network-based analysis with MIENTURNET visualized in Cytoscape. Across KEGG, Reactome, Gene Ontology and MSigDB Hallmark gene sets, the documented targets converged on cell-cycle regulation, G1/S transition, RB/E2F signaling, p53 signaling, apoptosis, senescence, PI3K-Akt and mTOR signaling, and DNA damage-associated processes. The network analysis identified ten genes connected to three of the four input microRNAs: CCND1, CCND2, E2F1, E2F3, MYC, PTEN, RB1, SMAD4, VEGFA and WEE1. The authors are careful to note that because the microRNAs were selected a priori for their known involvement in these pathways, the enrichment results annotate the predefined panel rather than independently validating the qPCR findings, and the network remains a hypothesis-generating framework rather than demonstrated regulation.

The mechanistic implications are nonetheless compelling. The persistent depletion of miR-34a-5p across all three A-T backgrounds fits squarely within the ATM-p53 checkpoint axis, since ATM is an upstream regulator of p53 activation and miR-34a is a direct p53-responsive tumor-suppressive microRNA. Importantly, the data support impaired normalization rather than complete absence of inducibility: some A-T lines retained miR-34a-5p inducibility after bleomycin but never reached control-like abundance, a nuance that distinguishes this work from earlier radiation studies in lymphocytes where the miR-34a response was not strongly discriminatory between A-T and control samples. The AT648-specific induction of miR-106b-5p and miR-20a-5p further nominates a p21/RB/E2F checkpoint hypothesis, because miR-106b family members can repress CDKN1A/p21, the major p53 effector of G1/S arrest, and miR-20a modulates E2F1, which intersects functionally with ATM-dependent p53 phosphorylation and apoptosis. Persistent depletion of miR-26a-5p, meanwhile, nominates WEE1, CHK1 and related checkpoint axes for validation.

The authors are equally explicit about the limitations that bound their conclusions. Only one ATM-proficient control line was included, and each A-T line represents a single donor, so donor-specific effects cannot be definitively separated from disease-associated ones. The sample size of three biological replicates per condition limits statistical power, no multiplicity correction was applied across the full set of comparisons, and a single endogenous normalizer, miR-16-5p, is less robust than a geometric mean of multiple validated references. Only one bleomycin dose and one 24-hour recovery time point were tested, mature microRNA abundance was measured without assessing pri-miRNA, AGO loading or target repression, and the database-derived candidate targets were not validated at the mRNA or protein level. Differences in immortalization and transformation status among the cell lines may also have shaped the line-specific responses.

What the study ultimately delivers is a checkpoint-centered model that is genuinely testable. A-T fibroblasts appear to carry a stable, shared depletion of selected ATM, p53 and DNA damage response-associated microRNAs, combined with cell-line-specific stress-induced remodeling of G1/S and RB/E2F-associated microRNA networks. The proposed next steps are concrete: measure p53 activation, p21, WEE1, CHK1, RB1, E2F1, E2F3, the cyclins, CDK6, BCL2, BCL2L11 and PTEN at mRNA and protein levels under the same conditions; prioritize the AT648 line for cell-cycle profiling after bleomycin; and, most decisively, restore miR-34a-5p or miR-26a-5p with mimic experiments to test whether candidate targets and checkpoint phenotypes shift in the expected direction. For a rare disease in which the non-coding RNA literature remains thin, this work provides a clear, mechanistically grounded map of where to look next, and a reminder that in A-T, microRNA biology is model-dependent, stimulus-dependent and time-dependent rather than reducible to any single signature.

Subject of Research: Dysregulation of DNA damage response-associated microRNAs in ataxia-telangiectasia fibroblasts

Article Title: DNA damage response associated miRNA dysregulation in Ataxia-telangiectasia

Article References: Iqbal, M. J., Bucci, C., Ricci, A., Morganti, G., Khan, F. I., Khan, M. J., & Menotta, M. (2026). DNA damage response associated miRNA dysregulation in Ataxia-telangiectasia. Molecular Biology Reports, 53(1), Article 1660. https://doi.org/10.1007/s11033-026-12860-1

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12860-1

Keywords: ataxia-telangiectasia, ATM kinase, microRNA, DNA damage response, miR-34a-5p, miR-26a-5p, p53 signaling, bleomycin, cell-cycle checkpoint, RB/E2F, fibroblasts, genome instability